Avion Wealth’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Avion Wealth’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-460	Closed	-$19K	–	1240
2023 Q4	$19K	Hold	460	–	–	0.01%	217
2023 Q3	$18K	Hold	460	–	–	0.01%	225
2023 Q2	$18K	Hold	460	–	–	﹤0.01%	241
2023 Q1	$18K	Hold	460	–	–	﹤0.01%	224
2022 Q4	$18K	Hold	460	–	–	0.01%	221
2022 Q3	$18K	Hold	460	–	–	0.01%	225
2022 Q2	$19K	Hold	460	–	–	0.01%	208
2022 Q1	$21K	Hold	460	–	–	0.01%	181
2021 Q4	$21K	Hold	460	–	–	0.01%	177
2021 Q3	$22K	Hold	460	–	–	0.01%	174
2021 Q2	$24K	Hold	460	–	–	0.01%	166
2021 Q1	$23K	Hold	460	–	–	0.01%	163
2020 Q4	$24K	Hold	460	–	–	0.01%	174
2020 Q3	$20K	Buy	+460	New	+$20.2K	0.01%	142

Other funds holding XPH

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Avion Wealth's XPH Position: Q1 2024 in Review

Avion Wealth sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2024, closing a stake of 460 shares — an estimated $19K sold.

Avion Wealth first reported a position in XPH in Q3 2020 and held it in 14 quarters. The position peaked at $24K in Q2 2021. 73 funds tracked by Wall St. Rank hold XPH as of Q1 2024.

Avion Wealth reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2024 after selling out during the quarter.
Avion Wealth sold 460 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2024, an estimated $19K.
Avion Wealth first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2020 and held it in 14 quarters.
Avion Wealth's State Street SPDR S&P Pharmaceuticals ETF position peaked at $24K in Q2 2021.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2024.

Based on Avion Wealth's 13F filing for Q1 2024, filed 3 May 2024.